Journal article
Immunogenicity of constitutively active V599EBRaf
Activating BRAF somatic missense mutations within the kinase domain are present in 60-66% of melanomas. The vast majority of these represent a single substitution of glutamate for valine (V599E). Here, we demonstrate spontaneous HLA-B*2705-restricted cytotoxic T-cell responses against an epitope derived from (V599E)BRaf.
These T-cell responses were mutation specific as the corresponding epitope derived from wild-type BRaf was not recognized. The loss of the (V599E)BRAF genotype during progression from primary to metastatic melanoma in patients with (V599E)BRaf specific T-cell responses suggests an active immune selection of nonmutated melanoma clones by the tumor-bearing host.
Language: | English |
---|---|
Year: | 2004 |
Pages: | 5456-5460 |
ISSN: | 15387445 and 00085472 |
Types: | Journal article |
DOI: | 10.1158/0008-5472.CAN-04-0937 |